NCT00287963View on ClinicalTrials.gov

Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Lung Cancer
Interventions
DRUG

topotecan hydrochloride

DRUG

vinorelbine tartrate

Trial Locations (1)

29425

Hollings Cancer Center at Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT00287963 - Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer | Biotech Hunter | Biotech Hunter